Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Lee's Pharmaceutical Holdings Limited

李 氏 大 藥 廠 控 股 有 限 公 司 *

(incorporated in the Cayman Islands with limited liability)

(Stock code: 950)

FORFEITURE OF UNCLAIMED DIVIDENDS

According to the articles of association of Lee's Pharmaceutical Holdings Limited (the "Company"), any dividend unclaimed for six years from the date of declaration of such dividend may be forfeited by the board of directors (the "Board") of the Company and shall revert to the Company.

The Board of the Company wishes to inform its shareholders that the following dividends remaining unclaimed on 28 November 2020 will be forfeited and reverted to the Company:

Type of Dividends

Date of Declaration

Date of Payment

Dividend Per Share

2013

Final Dividend

20 March 2014

12 June 2014

HK$ 0.052

2014

Interim Dividend

25 August 2014

16 October 2014

HK$ 0.027

Shareholders of the Company who are entitled to but yet to receive the dividend payments in respect of the above dividends are advised to contact the Company's branch share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not later than 28 November 2020.

By order of the Board

Lee's Pharmaceutical Holdings Limited

Lee Siu Fong

Chairman

Hong Kong, 28 August 2020

* For identification purpose only

As at the date of this announcement, Ms. Lee Siu Fong (Chairman), Ms. Leelalertsuphakun Wanee and Dr. Li Xiaoyi are executive directors of the Company, Mr. Simon Miles Ball is a non-executive director of the Company, Dr. Chan Yau Ching, Bob, Mr. Lam Yat Cheong and Dr. Tsim Wah Keung, Karl are independent non-executive directors of the Company.

Attachments

  • Original document
  • Permalink

Disclaimer

Lee's Pharmaceutical Holdings Limited published this content on 28 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 August 2020 10:08:07 UTC